Tuesday, December 03, 2019 2:57:33 PM
Your intelligent, articulate, reasoned response is much appreciated. Dowling is not over his head - there's a lot going on and his strategic, pragmatic, sound approach and personality is what you want in a CEO. Watch his video on Yahoo finance and think if that's a CEO you trust.
To say Tomc is a bs-er, well you lose it all there. The most dynamic, passionate, knowledgeable speak on any subject in my over 60 years of life. Top notch. Watch any of his videos but don't expect to go to sleep any time soon; because he will get you revved up.
Duffy, "whatever he is doing". LOL. Duffy is an acknowledged leader in the natural foods/supplement regulatory space. A physician. A lot of what he does goes on behind the scenes, but I guarantee it's all toward goal of making this company a long-term success. Check out the videos of him speaking to Congress and FDA. Top notch.
Right now, SP sucks but company is sound. Sometimes it goes that way, but not for long.
MT
To say Tomc is a bs-er, well you lose it all there. The most dynamic, passionate, knowledgeable speak on any subject in my over 60 years of life. Top notch. Watch any of his videos but don't expect to go to sleep any time soon; because he will get you revved up.
Duffy, "whatever he is doing". LOL. Duffy is an acknowledged leader in the natural foods/supplement regulatory space. A physician. A lot of what he does goes on behind the scenes, but I guarantee it's all toward goal of making this company a long-term success. Check out the videos of him speaking to Congress and FDA. Top notch.
Right now, SP sucks but company is sound. Sometimes it goes that way, but not for long.
MT
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
